Stay updated on Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.

Latest updates to the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added. The previous funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check20 days agoChange DetectedDifference0.5%

- Check28 days agoChange DetectedGlossary display was added and the QC label now reads 'Last Update Submitted that Met QC Criteria'. The page revision is updated to v3.4.0 and the No FEAR Act Data label was added while the lowercase 'No FEAR Act data' and the old revision v3.3.4 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is displayed and Revision: v3.3.3 is removed, indicating a minor version update to the page. No study content or key details appear to be changed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new Locations section featuring Mecklenburg-Vorpommern and removed the prior Mecklenburg-Vorpommern Locations subsection as part of revision v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Publications section description was updated to clarify that entries are automatically filled from PubMed and may not pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.